Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis

Abstract Trastuzumab combined with chemotherapy is standard of care for HER2 positive advanced gastro-esophageal cancers. The reported prevalence of HER2 discordance between primary tumors and corresponding metastases varies, hampering uniform patient selection for HER2 targeted therapy. This meta-a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. Creemers, E. ter Veer, L. de Waal, P. Lodder, G. K. J. Hooijer, N. C. T. van Grieken, M. F. Bijlsma, S. L. Meijer, M. G. H. van Oijen, H. W. M. van Laarhoven
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/256dfbed0fe34b36901003d0614a20f9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!